HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 129 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $129,000 | -83.4% | 10,193 | -75.2% | 0.00% | -100.0% |
| Q1 2022 | $777,000 | -45.1% | 41,121 | +2.0% | 0.00% | -50.0% |
| Q4 2021 | $1,415,000 | -0.8% | 40,311 | +3.5% | 0.00% | 0.0% |
| Q3 2021 | $1,427,000 | -3.9% | 38,966 | +3.1% | 0.00% | 0.0% |
| Q2 2021 | $1,485,000 | +41.3% | 37,803 | +1.6% | 0.00% | 0.0% |
| Q1 2021 | $1,051,000 | -10.5% | 37,200 | +1.5% | 0.00% | 0.0% |
| Q4 2020 | $1,174,000 | +1.6% | 36,645 | +2.4% | 0.00% | 0.0% |
| Q3 2020 | $1,156,000 | +19.7% | 35,792 | +2.2% | 0.00% | 0.0% |
| Q2 2020 | $966,000 | +74.1% | 35,031 | +6.6% | 0.00% | 0.0% |
| Q1 2020 | $555,000 | -31.0% | 32,857 | +1.7% | 0.00% | 0.0% |
| Q4 2019 | $804,000 | +42.0% | 32,302 | -2.3% | 0.00% | +100.0% |
| Q3 2019 | $566,000 | – | 33,050 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zeal Asset Management Ltd | 2,684,118 | $84,523,000 | 16.48% |
| Cederberg Capital Ltd | 3,400,000 | $108,868,000 | 2.00% |
| Capital International Sarl | 570,500 | $18,267,000 | 1.91% |
| AIA Group Ltd | 437,118 | $14,971,000 | 1.72% |
| Capital International, Inc./CA/ | 4,711,405 | $150,859,000 | 1.40% |
| M&G INVESTMENT MANAGEMENT LTD | 3,096,345 | $99,083,000 | 0.62% |
| Bellevue Group AG | 947,674 | $30,345,000 | 0.35% |
| Sands Capital Management | 7,051,916 | $225,802,000 | 0.22% |
| E Fund Management (Hong Kong) Co., Ltd. | 18,836 | $603,000 | 0.21% |
| Hudson Bay Capital Management LP | 1,031,212 | $33,020,000 | 0.18% |